SGLT2 inhibitors and sleep apnea; how helpful are the medications: A meta-analysis

Background: Sleep disordered breathing (SDB) has a close association with diabetes, especially in obese patients. The use of sodium-glucose co-transporter-2 (SGLT2) inhibitors in patients with diabetes with SDB is a debate with conflicting evidence. We aim to study the effect of SGLT2 inhibitors on...

Full description

Bibliographic Details
Main Authors: Tanveer Mir, Hassan Bin Atique, Neelambuj Regmi, Yasar Sattar, Saira Sundus, Sabah Ambreen, Prateek Lohia, Waqas T. Qureshi, Ayman Soubani
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:Endocrine and Metabolic Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666396121000078